Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
S-adenosylmethionine (SAM)-dependent methyltransferases are a family of enzymes that utilize SAM as a cofactor to transfer a methyl group to a variety of substrates, including DNA, RNA, proteins, lipids, and small molecules. This methylation process is crucial for a wide range of biological functions, including epigenetic regulation, biosynthesis, and detoxification. Aberrant activity of these enzymes is implicated in various diseases.
Inhibition of methyl group transfer
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on S-adenosylmethionine (SAM)-dependent Methyltransferase (SAM-MT).